Rupintrivir
Rupintrivir is a protease inhibitor that was originally developed for the treatment of rhinovirus infections. It is a 3C protease inhibitor, which means it inhibits the 3C protease enzyme, a crucial component in the life cycle of picornaviruses. Rupintrivir was developed by Agouron Pharmaceuticals, a subsidiary of Pfizer.
History[edit | edit source]
Rupintrivir was first synthesized in the late 1990s by Agouron Pharmaceuticals. The drug was developed as a potential treatment for the common cold, which is most often caused by rhinovirus infections. However, despite showing promise in early-stage clinical trials, development of the drug was discontinued in the early 2000s due to a lack of efficacy in later-stage trials.
Mechanism of Action[edit | edit source]
Rupintrivir works by inhibiting the 3C protease enzyme, a key component in the life cycle of picornaviruses. By blocking this enzyme, the drug prevents the virus from replicating and spreading within the body.
Clinical Trials[edit | edit source]
In early-stage clinical trials, rupintrivir was shown to reduce the duration and severity of cold symptoms in patients infected with rhinovirus. However, in later-stage trials, the drug did not show a significant benefit over placebo, leading to the discontinuation of its development.
Future Research[edit | edit source]
Despite the discontinuation of rupintrivir's development, research into 3C protease inhibitors continues. These drugs have the potential to treat a wide range of viral infections, including those caused by enteroviruses and noroviruses.
See Also[edit | edit source]
Rupintrivir Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD